Contact us
  • Add: 509, FuXin International Building, No.359 HongWu Road, BaiXia District, Nanjing 210002, P.R. China.
  • Tel: 86-25-8456 3290
  • Fax: 86-25-8427 0111
  • E-Mail:  


Get E-mail on new products

Many Years, Hurdles Remain

'Many Years, Hurdles Remain'

University of California, San Diego professor of bioengineering John T. Watson, PhD, calls the 20-dose trial an important first step in showing that a programmable drug-delivery microchip is possible.

But he tells WebMD that many years and hurdles remain before the technology reaches the clinic.

In an editorial published with the study today in the journal Science Translational Medicine, Watson writes that although the road may be long and winding, "a versatile, implantable device that exploits the microchip approach for controlled drug delivery will be worth the wait for patients with chronic diseases."

The study was funded and overseen by MicroCHIPS Inc.